Clinical Study
Hypertension Control and Cardiometabolic Risk: A Regional Perspective
Table 9
Blood pressure and CRP (mg/dL ± SD, adjusted for age, and gender).
| | Total
() | Northern Europe
() | Southern Europe
() | North America
() | Middle East
() | Asia
() | value |
| | SBP (mmHg) | | | | | | | | | <120 | 0.7 (0.090) | 0.8 (0.131) | 0.8 (0.160) | 0.6 (0.284) | 0.6 (0.576) | 0.1 (0.304) | 0.3399 | | 120–139 | 0.7 (0.037) | 0.7 (0.062) | 0.8 (0.053) | 0.4 (0.154) | 0.4 (0.286) | 0.4 (0.139) | 0.0141 | | 140–159 | 0.9 (0.030) | 1.0 (0.043) | 0.9 (0.050) | 0.5 (0.146) | 1.1 (0.145) | 0.5 (0.133) | 0.0009 | | 160–179 | 1.1 (0.041) | 1.1 (0.055) | 1.1 (0.070) | 0.5 (0.250) | 0.9 (0.168) | 0.6 (0.219) | 0.0196 | | ≥180 | 1.1 (0.066) | 1.3 (0.087) | 0.8 (0.117) | 1.1 (0.301) | 0.8 (0.230) | 0.3 (0.500) | 0.0097 | | value | <0.0001 | <0.0001 | 0.0520 | 0.0356 | 0.4130 | 0.3783 | | | DBP (mmHg) | | | | | | | | | <90 | 0.8 (0.027) | 0.8 (0.038) | 0.8 (0.043) | 0.4 (0.112) | 0.9 (0.164) | 0.4 (0.114) | <0.0001 | | 90–99 | 1.0 (0.035) | 1.1 (0.049) | 0.9 (0.058) | 0.6 (0.187) | 1.1 (0.150) | 0.6 (0.155) | 0.0022 | | 100–109 | 1.1 (0.050) | 1.3 (0.072) | 1.0 (0.078) | 1.0 (0.293) | 0.8 (0.193) | 0.4 (0.253) | 0.0013 | | ≥110 | 1.0 (0.091) | 1.2 (0.130) | 0.8 (0.158) | 0.6 (0.424) | 0.9 (0.338) | 0.9 (0.456) | 0.3130 | | value | <0.0001 | <0.0001 | 0.4665 | 0.0056 | 0.5488 | 0.1511 | | | RR (mmHg) | | | | | | | | | uncontrolled* | 1.0 (0.028) | 1.1 (0.031) | 0.9 (0.037) | 0.6 (0.114) | 0.9 (0.096) | 0.5 (0.106) | <0.0001 | | controlled** | 0.8 (0.026) | 0.7 (0.061) | 0.8 (0.054) | 0.4 (0.143) | 0.6 (0.348) | 0.4 (0.140) | 0.0057 | | value | <0.0001 | <0.0001 | 0.1596 | 0.2786 | 0.4071 | 0.1582 | |
|
|
*SBP/DBP ≥140/90 in non-diabetic and ≥130/80 in diabetic patients, **<140/90 in non-diabetic and <130/80 in diabetic patients.
|
